Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Neurofibromatosis 1 9Breast Neoplasms 5Neurofibroma, Plexiform 4Lung Neoplasms 4Triple Negative Breast Neoplasms 3Neurofibrosarcoma 3Thyroid Neoplasms 2Neoplasms 2Melanoma 2Gallbladder Neoplasms 2Uveal Melanoma 1Thyroid Diseases 1Thyroid Cancer, Papillary 1Sarcoma, Kaposi 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Non-small Cell Lung Cancer Metastatic 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neoplasm Metastasis 1Meningioma 1Liver Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Glioma 1

Interventions

Iodine-131 5dabrafenib 4Vemurafenib 4Magnetic Resonance Spectroscopy 4trametinib 3lenvatinib 3Transurethral Resection of Prostate 3Thyrotropin Alfa 3Thyroidectomy 3selpercatinib 2cobimetinib 2X-Rays 2Thyroid (USP) 2Surgical Procedures, Operative 2Sunitinib 2Specimen Handling 2Radiofrequency Ablation 2Interviews as Topic 2vandetanib 1tremelimumab 1spartalizumab 1pembrolizumab 1pazopanib 1durvalumab 1delta 24-sterol reductase 1copanlisib 1cabozantinib 1Whole Body Imaging 1Thyrotropin 1Thalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Thyroid Cancer, Papillary × AZD 6244 × Clear all
NCT02393690 2024-07-26

Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer

Academic and Community Cancer Research United

Phase 2 Completed
60 enrolled 12 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡